Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

4.70
Delayed Data
As of Aug 28
 +0.10 / +2.17%
Today’s Change
4.25
Today|||52-Week Range
12.88
-49.95%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues31.5M53.8M33.9M47.0M
 
 
 
 
 
Cost of Goods Sold11.7M14.8M11.1M13.8M
 
 
 
 
 
Depreciation And Amortization10.2M18.7M18.4M22.3M
 
 
 
 
 
 
Operating ExpensesGross Income9.6M20.3M4.4M10.9M
 
 
 
 
 
General Expenses15.3M22.9M22.0M23.2M
 
 
 
 
 
Research And Development290.0K2.3M994.0K1.5M
 
 
 
 
 
Total Operating Expenses37.2M56.4M51.5M59.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.7M-2.5M-17.6M-12.4M
 
 
 
 
 
Extraordinary Credit0.000.00--8.7M
 
 
Extraordinary Charge--0.00-1.3M-22.5M
 
 
 
Interest Expense On Debt5.3M10.0M9.4M9.9M
 
 
 
 
 
Other Expenses6.0K-82.0K0.000.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.0M-12.6M-28.2M-35.8M
 
 
 
 
 
Income Taxes-655.0K-4.8M-4.6M-3.6M
 
 
 
 
 
Net Income-11.7M-7.8M-23.7M-32.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS38.1M38.3M38.5M52.4M
 
 
 
 
 
Shares To Calculate EPS Diluted38.1M38.3M38.5M52.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.31-$0.20-$0.62-$0.62
 
 
 
 
 
EPS Diluted-$0.31-$0.20-$0.62-$0.62